Tag: Levi Garraway

  • Campus & Community

    Three appointed as investigators

    Howard Hughes Medical Institute appoints Levi Garraway, Pardis Sabeti, and Tobias Walther as investigators.

    4–6 minutes
  • Health

    Mutations drive malignant melanoma

    Two mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what Harvard scientists call the “dark matter” of the cancer genome, where cancer-related mutations haven’t been previously found.

    3–5 minutes
  • Health

    Genes tied to prostate cancer uncovered

    For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease.

    4–7 minutes
  • Health

    Critical finding for skin cancer treatment

    Researchers’ findings pinpoint a critical gene involved in melanoma growth, and provide a framework for discovering ways to tackle cancer drug resistance.

    4–6 minutes
  • Health

    Nine Harvard faculty members win NIH’s Pioneer, Innovator Awards

    Nine Harvard researchers “well-positioned to make significant – and potentially transformative – discoveries in a variety of areas,” ranging from brain development to reprogramming stem cells, have been awarded special funding by the National Institutes of Health (NIH). The grants, announced Tuesday (Sept. 18), total $15 million over the next five years. They will be…

    1–2 minutes
  • Health

    Scientists identify normal gene driving the growth and survival of melanoma cells

    Dana-Farber’s Levi Garraway, M.D., Ph.D., and William Sellers, M.D., the paper’s first and senior authors, and their colleagues reported their findings in the July 7, 2005 issue of the journal Nature. The researchers used single nucleotide polymorphism (SNP) array technology, which focuses on the building blocks of individual genes, to identify regions of chromosomes where…

    1–2 minutes